Provided by Tiger Fintech (Singapore) Pte. Ltd.

NFT Concept

856.09
+3.100.36%
Number of Gainers:5
Number of Losers:7
Number of Flat:1
PE:- -
High:856.10
Open:834.03
Low:829.24
Close:852.99
Volume:74.27M
Turnover:4.18B
Market Cap:520.38B
Float Cap:464.66B

Loading ...

Clean Energy Heating Project Launches in Tibet's Ngari Prefecture, Solar Power Warms 4,700-Meter Plateau

Deep News
·
5 hours ago

Alibaba’s Stock Surge: A Strong Buy Amidst Market Optimism

TIPRANKS
·
Yesterday

Yuhang, Hangzhou: Channeling Talent to Nourish Industries and Painting a Shared Prosperity Vision for Urban-Rural Development

Deep News
·
Yesterday

TC Energy, PENN, DraftKings, Trade Desk: Trending by Analysts

TIPRANKS
·
Yesterday

Tmall's Double 11: Over 70% of Top Brands' GMV Driven by 88VIP Members

Deep News
·
Yesterday

Ant CEO Han Xinyi: Foreign Users Served by Alipay in China Grow 77% YoY from Jan-Sept

Deep News
·
Yesterday

DraftKings Chief Legal Officer R. Stanton Dodge Reports Disposal of Common Shares

Reuters
·
Yesterday

Roblox Chief Legal Officer Mark Reinstra Reports Disposal of Common Shares

Reuters
·
Yesterday

Boxlight Expands Inventory Financing Agreement With J.J. Astor to $9 Million

Reuters
·
Yesterday

Three Directors Resign from Singularity Future Technology Ltd

Reuters
·
Yesterday

Mixed options sentiment in Alibaba with shares down 1.15%

TIPRANKS
·
Yesterday

DraftKings Q3 Sports Betting Results Disappoint Analyst: 'No Way To Describe … Other Than Ugly'

Benzinga_recent_news
·
Yesterday

DraftKings Says It Will Use Prediction Markets to Pressure States on Sports Betting -- Barrons.com

Dow Jones
·
Yesterday

Susquehanna Remains a Buy on DraftKings (DKNG)

TIPRANKS
·
Yesterday

DraftKings Is Maintained at Buy by Benchmark

Dow Jones
·
Nov 07

ESPN Shifts Partnership from Penn to DraftKings

Deep News
·
Nov 07

Dolphin Entertainment Inc. to Announce Third Quarter 2025 Results

Reuters
·
Nov 07

BUZZ-DraftKings drops as Q3 revenue falls short of estimates

Reuters
·
Nov 07

Press Release: Xilio Therapeutics Announces Late-Breaking Phase 2 Data for Vilastobart in Patients with MSS mCRC and High Plasma Tumor Mutational Burden at Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting

Dow Jones
·
Nov 07

Xilio Therapeutics Highlights Portfolio of Differentiated Masked Immunotherapies at Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting

GlobeNewswire
·
Nov 07